These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1131 related items for PubMed ID: 23401496

  • 1. Surgical or percutaneous mitral valve repair for secondary mitral regurgitation: comparison of patient characteristics and clinical outcomes.
    Conradi L, Treede H, Rudolph V, Graumüller P, Lubos E, Baldus S, Blankenberg S, Reichenspurner H.
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):490-6; discussion 496. PubMed ID: 23401496
    [Abstract] [Full Text] [Related]

  • 2. Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience.
    Taramasso M, Denti P, Buzzatti N, De Bonis M, La Canna G, Colombo A, Alfieri O, Maisano F.
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):920-6. PubMed ID: 22961958
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial.
    Reichenspurner H, Schillinger W, Baldus S, Hausleiter J, Butter C, Schäefer U, Pedrazzini G, Maisano F, ACCESS-EU Phase I Investigators.
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):e280-8. PubMed ID: 23864216
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of outcomes of percutaneous MitraClip versus surgical repair or replacement for degenerative mitral regurgitation in octogenarians.
    Buzzatti N, Maisano F, Latib A, Taramasso M, Denti P, La Canna G, Colombo A, Alfieri O.
    Am J Cardiol; 2015 Feb 15; 115(4):487-92. PubMed ID: 25529545
    [Abstract] [Full Text] [Related]

  • 8. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry.
    Ohno Y, Attizzani GF, Capodanno D, Cannata S, Dipasqua F, Immé S, Barbanti M, Ministeri M, Caggegi A, Pistritto AM, Chiarandà M, Ronsivalle G, Giaquinta S, Farruggio S, Mangiafico S, Scandura S, Tamburino C, Capranzano P, Grasso C.
    Eur Heart J Cardiovasc Imaging; 2014 Nov 15; 15(11):1246-55. PubMed ID: 24939944
    [Abstract] [Full Text] [Related]

  • 9. Staged total percutaneous treatment of aortic valve pathology and mitral regurgitation: institutional experience.
    Kische S, D'Ancona G, Paranskaya L, Schubert J, Arsoy N, Hauenstein KH, Alozie A, Jovanovich B, Nienaber C, Ince H.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):E552-63. PubMed ID: 23359543
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study.
    Glower DD, Kar S, Trento A, Lim DS, Bajwa T, Quesada R, Whitlow PL, Rinaldi MJ, Grayburn P, Mack MJ, Mauri L, McCarthy PM, Feldman T.
    J Am Coll Cardiol; 2014 Jul 15; 64(2):172-81. PubMed ID: 25011722
    [Abstract] [Full Text] [Related]

  • 11. Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata.
    Paranskaya L, D'Ancona G, Bozdag-Turan I, Akin I, Kische S, Turan GR, Divchev D, Rehders TC, Schneider H, Ortak J, Nienaber CA, Ince H.
    EuroIntervention; 2012 Sep 15; 8(5):571-8. PubMed ID: 22995083
    [Abstract] [Full Text] [Related]

  • 12. Management of moderate secondary mitral regurgitation at the time of aortic valve surgery.
    Coutinho GF, Correia PM, Pancas R, Antunes MJ.
    Eur J Cardiothorac Surg; 2013 Jul 15; 44(1):32-40. PubMed ID: 23345178
    [Abstract] [Full Text] [Related]

  • 13. Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip® system is a risk factor for adverse one-year outcome.
    Paranskaya L, D'Ancona G, Bozdag-Turan I, Akin I, Kische S, Turan GR, Rehders T, Ortak J, Nienaber CA, Ince H.
    Catheter Cardiovasc Interv; 2013 Mar 15; 81(4):609-17. PubMed ID: 22887450
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.
    Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W.
    J Am Coll Cardiol; 2013 Sep 17; 62(12):1052-1061. PubMed ID: 23747789
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous edge-to-edge repair of the mitral valve in patients with degenerative versus functional mitral regurgitation.
    Braun D, Lesevic H, Orban M, Michalk F, Barthel P, Hoppe K, Sonne C, Pache J, Mehilli J, Kastrati A, Hausleiter J, Massberg S.
    Catheter Cardiovasc Interv; 2014 Jul 01; 84(1):137-46. PubMed ID: 24323541
    [Abstract] [Full Text] [Related]

  • 16. One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation.
    Pleger ST, Schulz-Schönhagen M, Geis N, Mereles D, Chorianopoulos E, Antaredja M, Lewening M, Katus HA, Bekeredjian R.
    Eur J Heart Fail; 2013 Aug 01; 15(8):919-27. PubMed ID: 23512096
    [Abstract] [Full Text] [Related]

  • 17. Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry.
    Attizzani GF, Ohno Y, Capodanno D, Cannata S, Dipasqua F, Immé S, Mangiafico S, Barbanti M, Ministeri M, Cageggi A, Pistritto AM, Giaquinta S, Farruggio S, Chiarandà M, Ronsivalle G, Schnell A, Scandura S, Tamburino C, Capranzano P, Grasso C.
    JACC Cardiovasc Interv; 2015 Jan 01; 8(1 Pt A):74-82. PubMed ID: 25499300
    [Abstract] [Full Text] [Related]

  • 18. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry).
    Grasso C, Capodanno D, Scandura S, Cannata S, Immè S, Mangiafico S, Pistritto A, Ministeri M, Barbanti M, Caggegi A, Chiarandà M, Dipasqua F, Giaquinta S, Occhipinti M, Ussia G, Tamburino C.
    Am J Cardiol; 2013 May 15; 111(10):1482-7. PubMed ID: 23433761
    [Abstract] [Full Text] [Related]

  • 19. MitraClip implantation for high risk patients with severe mitral regurgitation: the Sheba experience.
    Koifman E, Fefer P, Hay I, Feinberg M, Maor E, Guetta V.
    Isr Med Assoc J; 2014 Feb 15; 16(2):91-5. PubMed ID: 24645227
    [Abstract] [Full Text] [Related]

  • 20. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry.
    Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W.
    Eur Heart J; 2016 Feb 21; 37(8):703-12. PubMed ID: 26614824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.